Evidence map›Paper›PMID 42506315›Full record

SynthesisMedical sciences (Basel, Switzerland)2026

Nabiximols in Multiple Sclerosis: Beyond Spasticity-An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes.

Dénes Kleiner, István László Horváth, Dóra Mátis, Rita Nagy, Dorottya Gergő, Katalin Lugosi, Gábor Fazekas, Péter Fehérvári, Péter Hegyi, Dezső Csupor

Abstract readSystematic ReviewMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dénes KleinerUniversity Pharmacy, Department of Pharmacy Administration, Semmelweis University, Hőgyes Endre utca 7-9., 1092 Budapest, Hungary.
István László HorváthUniversity Pharmacy, Department of Pharmacy Administration, Semmelweis University, Hőgyes Endre utca 7-9., 1092 Budapest, Hungary.ORCID 0009-0001-4023-6099
Dóra MátisCentre for Translational Medicine, Semmelweis University, Baross utca 22, 1085 Budapest, Hungary.
Rita NagyCentre for Translational Medicine, Semmelweis University, Baross utca 22, 1085 Budapest, Hungary.
Dorottya GergőCentre for Translational Medicine, Semmelweis University, Baross utca 22, 1085 Budapest, Hungary.ORCID 0000-0002-2726-3463
Katalin LugosiCentre for Translational Medicine, Semmelweis University, Baross utca 22, 1085 Budapest, Hungary.
Gábor FazekasRehabilitation Clinic, Semmelweis University, Szanatórium utca 19, 1121 Budapest, Hungary.ORCID 0000-0003-3612-8826
Péter FehérváriCentre for Translational Medicine, Semmelweis University, Baross utca 22, 1085 Budapest, Hungary.
Péter HegyiCentre for Translational Medicine, Semmelweis University, Baross utca 22, 1085 Budapest, Hungary.
Dezső CsuporCentre for Translational Medicine, Semmelweis University, Baross utca 22, 1085 Budapest, Hungary.ORCID 0000-0002-4088-3333

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabidiolDronabinolMultiple SclerosisMuscle SpasticityDrug CombinationsHumansTreatment OutcomeCannabidiolDronabinolDrug Combinationsnabiximolsbladder functionmultiple sclerosisSativexsleep disruptionspasmsTHC/CBD

Identifiers

PMID42506315
PMCPMC13413933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.